Skip to content
Trial Eligibility
Menu

Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder

NCT06830044

This study is recruiting at 25 US sites in 16 states, according to its ClinicalTrials.gov record last updated .

Summary

The purpose of this study is to determine the efficacy and safety of milsaperidone compared to placebo as adjunctive therapy in patients with Major Depressive Disorder

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Major Depressive Disorder (MDD)

Eligibility basics and study details

Study type
Interventional
Phase
Phase 3
Ages
18 to 65 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
Vanda Pharmaceuticals
Last updated on ClinicalTrials.gov
September 24, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Arizona · 1

  • Vanda Investigational Site · Phoenix, AZ

Arkansas · 1

  • Vanda Investigational Site · Little Rock, AR

California · 5

  • Vanda Investigational Site · Garden Grove, CA
  • Vanda Investigational Site · Orange, CA
  • Vanda Investigational Site · Redlands, CA
  • Vanda Investigational Site · San Jose, CA
  • Vanda Investigational Site · Walnut Creek, CA

Colorado · 1

  • Vanda Investigational Site · Colorado Springs, CO

Florida · 2

  • Vanda Investigational Site · Fort Myers, FL
  • Vanda Investigational Site · Miami, FL

Georgia · 1

  • Vanda Investigational Site · Snellville, GA

Illinois · 1

  • Vanda Investigational Site · Chicago, IL

Indiana · 1

  • Vanda Investigational Site · Carmel, IN

Massachusetts · 1

  • Vanda Investigational Site · Boston, MA

Missouri · 1

  • Vanda Investigational Site · Saint Charles, MO

Nevada · 1

  • Vanda Investigational Site · Las Vegas, NV

New York · 3

  • Vanda Investigational Site · New York, NY
  • Vanda Investigational Site · New York, NY
  • Vanda Investigational Site · Staten Island, NY

North Carolina · 1

  • Vanda Investigational Site · Charlotte, NC

Ohio · 1

  • Vanda Investigational Site · Cincinnati, OH

Texas · 3

  • Vanda Investigational Site · Houston, TX
  • Vanda Investigational Site · Plano, TX
  • Vanda Investigational Site · Richardson, TX

Washington · 1

  • Vanda Investigational Site · Bellevue, WA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.